Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000578767 | SCV000680493 | pathogenic | not provided | 2018-11-30 | criteria provided, single submitter | clinical testing | The R107X nonsense variant in the ABCA4 gene has been published as a pathogenic variant in association with ABCA4-related disorders (Burke et al., 2010; Kjellström et al., 2015; Jiang et al., 2016). This pathogenic variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The R107X variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016). This variant is interpreted to be pathogenic. |
Blueprint Genetics | RCV001075053 | SCV001240664 | pathogenic | Retinal dystrophy | 2018-06-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000578767 | SCV001376861 | pathogenic | not provided | 2025-01-06 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg107*) in the ABCA4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ABCA4 are known to be pathogenic (PMID: 10958761, 24938718, 25312043, 26780318). This variant is present in population databases (rs765429911, gnomAD 0.006%). This premature translational stop signal has been observed in individuals with Stargardt disease or cone-rod dystrophy (PMID: 20696155, 26261413, 26780318). ClinVar contains an entry for this variant (Variation ID: 488674). For these reasons, this variant has been classified as Pathogenic. |
Ocular Genomics Institute, |
RCV001376340 | SCV001573454 | pathogenic | Severe early-childhood-onset retinal dystrophy | 2021-04-08 | criteria provided, single submitter | research | The ABCA4 c.319C>T variant was identified in an individual with retinitis pigmentosa with a presumed recessive inheritance pattern. Through a review of available evidence we were able to apply the following criteria: PM2, PVS1, PM3. Based on this evidence we have classified this variant as Pathogenic. |
Institute of Human Genetics, |
RCV001075053 | SCV005071527 | pathogenic | Retinal dystrophy | 2022-01-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005027679 | SCV005656509 | pathogenic | Cone-rod dystrophy 3; Age related macular degeneration 2; Severe early-childhood-onset retinal dystrophy; Retinitis pigmentosa 19 | 2024-05-16 | criteria provided, single submitter | clinical testing |